首页 / 院系成果 / 成果详情页

A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma. 会议论文

编号：

2AA730D43004CCD20C4E333D0BA0A806
作者：

Zhang, Taiping^[1] Wang, Liwei^[2] Cao, Zhe Cui, Jiujie Wu, Shikai^[3] Tian, Xiaodong^[4] He, Yifu^[5] Zhou, JianWei^[6] Yu, Xianjun^[7] Peng, Zhigang^[8] Qin, Yanru^[9] Zhou, Xinhua^[10] Tian, Yifeng^[11] Tian, Jing^[12] Tan, Hai Dong^[13] Zhang, Wenjing^[14] Liu, Hongli^[15] Fan, Lingli^[16] Sun, Yongkun^[17] Zhao, Yupei
语种：

英文
会议名称：

JOURNAL OF CLINICAL ONCOLOGY
会议地点：

Chicago, IL
收录：
推荐引用方式
GB/T 7714：

Zhang Taiping,Wang Liwei,Cao Zhe, et al. A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma. [J].JOURNAL OF CLINICAL ONCOLOGY,2026,44(16_SUPPL):e16399-e16399.
APA：

Zhang Taiping,Wang Liwei,Cao Zhe,Cui Jiujie,&Zhao Yupei.(2026).A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma. .JOURNAL OF CLINICAL ONCOLOGY,44(16_SUPPL):e16399-e16399.
MLA：

Zhang Taiping, et al. "A multicenter, prospective real-world study of irinotecan liposome (II)-based combination regimens in patients with pancreatic ductal adenocarcinoma." .JOURNAL OF CLINICAL ONCOLOGY 44,16_SUPPL(2026):e16399-e16399.
入库时间：

2026/6/17 8:23:25
更新时间：

2026/6/17 8:23:25

浏览次数：14  下载次数：0

浏览次数：14

下载次数：0

打印次数：0